Recombinant Cat Suppressor of tumorigenicity 7 protein (ST7)

What is the Suppressor of Tumorigenicity 7 (ST7) protein and where is it located in the genome?

ST7 has been identified as a tumor suppressor gene located in chromosome region 7q31.1-q31.2. The protein plays a significant role in cancer suppression through regulation of cellular structure maintenance and oncogenic pathway modulation .

What is the subcellular localization pattern of ST7 protein?

Studies using fluorescently tagged ST7 fusion proteins (GFP, YFP, or V5) demonstrated predominantly cytosolic expression in multiple cancer cell lines including HCT-116 (colorectal cancer), MCF-7 (breast cancer), and PC-3 (prostate cancer). Notably, translocation from cytoplasm to nucleus has not been observed under any experimental conditions tested .

How does ST7 expression change throughout the cell cycle?

Cell cycle synchronization experiments reveal that ST7 expression is significantly upregulated when cells are in arrested states. When cells re-enter division status, ST7 expression levels markedly decrease. This expression pattern suggests ST7 may function as a cell cycle regulator, potentially contributing to its tumor suppressor activity .

What expression vectors are effective for studying ST7 in laboratory settings?

Research indicates successful use of a gateway cloning system with various tags (GFP, YFP, or V5) for creating ST7 expression vectors. Full-length ST7 cDNA isolated from human adult brain cDNA library serves as an effective template for these constructions .

What cell synchronization methods are recommended for studying ST7's cell cycle-dependent expression?

While specific synchronization protocols weren't detailed in available studies, cell cycle synchronization has been successfully employed to analyze ST7 expression at different cell cycle stages. This methodology is critical for understanding ST7's variable expression patterns and potential regulatory mechanisms throughout the cell cycle .

What experimental controls should be included when investigating ST7 function?

Based on established research methodologies, appropriate controls for ST7 studies should include: untransfected cells, vector-only controls, non-targeting siRNA controls (for knockdown studies), and time-matched samples for expression analysis across cell cycle stages .

What genes show coordinated expression patterns with ST7 during cell cycle progression?

Research has identified SERPINE1 as demonstrating similar expression patterns to ST7 during cell cycle progression, with both genes showing elevated expression in arrested cells and reduced expression when cells re-enter division. Additionally, Survivin, MMP-13, and Cyclin D1 display differential expression during the cell cycle, suggesting potential functional relationships with ST7 .

How does ST7 mediate tumor suppression at the molecular level?

Evidence suggests ST7 mediates tumor suppression through regulation of genes involved in maintaining cellular structure and oncogenic pathways. This regulatory function appears to influence cell cycle progression and potentially other cancer-related cellular processes .

How might ST7 expression patterns be compared to other tumor suppressors used in cancer research?

While direct comparisons weren't provided in the available literature, ST7's cell cycle-dependent expression pattern (high in arrested cells, low in dividing cells) offers an interesting contrast to other tumor suppressors. This distinctive expression profile suggests specialized regulatory mechanisms that may complement other tumor suppression pathways .

How might research on ST7 inform development of cancer therapeutics targeting cell cycle regulation?

ST7's cell cycle-dependent expression pattern suggests it may represent a potential target for therapies that aim to restore proper cell cycle control in cancer cells. Understanding how ST7 regulates genes like Survivin, MMP-13, and Cyclin D1 could lead to novel approaches for modulating these critical oncogenic pathways .

What are potential approaches for studying ST7's role alongside other decoy receptors in cancer therapy?

Recent research on decoy receptors like sFzd7 has demonstrated effectiveness in inhibiting cancer cell growth by blocking signaling pathways (e.g., Wnt pathway). Similar approaches might be explored with ST7, particularly investigating whether ST7-derived constructs could function as decoy proteins to modulate cancer-related signaling pathways .

How might ST7 research integrate with studies of the Wnt signaling pathway in cancer?

Given that some decoy receptors (like sFzd7) show anti-tumor activity by inhibiting the Wnt signaling pathway, and that ST7 regulates Cyclin D1 (a Wnt target gene), future research might explore potential interactions between ST7 and Wnt pathway components. This could reveal whether ST7's tumor suppressive function involves direct or indirect modulation of Wnt signaling .

What statistical approaches are most appropriate for analyzing ST7 expression data across different cancer types?

Based on research methodologies, appropriate statistical approaches for ST7 expression analysis would include paired t-tests or ANOVA for comparing expression levels across different cell states or cancer types, with significance typically set at p<0.05. Correlation analyses may be valuable for examining relationships between ST7 and related genes like SERPINE1 .

How should researchers address potential confounding factors when studying ST7 in different cancer cell lines?

When conducting ST7 research across different cell lines, researchers should account for variations in baseline expression levels, genetic background differences, and tissue-specific regulatory mechanisms. Cell authentication, passage number standardization, and consistent culture conditions are critical for minimizing experimental variability .

What are recommended approaches for validating ST7's functional effects in cancer models?

A comprehensive validation strategy should include multiple complementary approaches: gene expression analysis (qRT-PCR), protein expression confirmation (Western blot), subcellular localization studies (immunofluorescence), and functional assays assessing proliferation, apoptosis, migration, and invasion. Both gain-of-function and loss-of-function studies should be conducted to fully characterize ST7's role .

Table 1: ST7 Cellular Localization in Cancer Cell Lines

Note: Localization determined via fluorescence signals from ST7 fusion proteins with GFP, YFP, or V5 tags

Table 2: Gene Expression Patterns During Cell Cycle in Relation to ST7

Note: Expression patterns observed in cell cycle synchronization studies

Table 3: Comparison of Cancer-Related Protein Functions

Note: Compiled from studies on tumor suppressor mechanisms

What novel experimental approaches might advance understanding of ST7's mechanism of action?

Future research should consider CRISPR/Cas9-mediated gene editing to create ST7 knockout models, proteomics analysis to identify ST7 interaction partners, and ChIP-seq to determine if ST7 influences gene expression through direct or indirect DNA interactions. Single-cell analysis might reveal heterogeneity in ST7 function across cell populations .

How might ST7 research integrate with studies of other tumor suppressors to develop combination therapies?

Investigating ST7 alongside established tumor suppressors could reveal synergistic mechanisms and potential for combination therapies. For example, exploring how ST7 might complement decoy receptor approaches (like soluble Fzd7) could identify novel therapeutic strategies for cancers with aberrant Wnt signaling .